MarketPeel
Insider Trading Intelligence
CS

Christopher Seiter

TRVI
CHIEF FINANCIAL OFFICER · TREVI THERAPEUTICS, INC. · CIK 0001774627
FILING MIX · LIFETIME100%/0%
BUYS
2
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
80,000
AVG SELL PX
TRADE KIND
SHOWING 2 / 2
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Christopher Seiter. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
TRVI · 80,000 shares · as of Feb 17, 2021
020,00040,00060,00080,0002021SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
FLOW · 2 buys / 0 sellsCOVERAGE · 5 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
TRVI
TREVI THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
80,00080,000Feb 17, 2021Feb 19, 2021
TRVI
TREVI THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
65,00065,000Feb 13, 2020Feb 18, 2020
Other insiders · TRVI
Loading peer insiders…
About this filer
CIK 0001774627
ROLE
Chief Financial Officer
PRIMARY
TRVI
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001774627DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback